RecruitingNot ApplicableNCT06287112

Prevention of Acute Cholecystitis With ETGBD

Efficacy of ETGBD Parallel Insertion With Fully Covered Self-expandable Metal Stent for Preventing Acute Cholecystitis in Patients With Low Cystic Duct Insertion


Sponsor

Seoul National University Hospital

Enrollment

35 participants

Start Date

Jun 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion. In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility.


Eligibility

Min Age: 19 Years

Inclusion Criteria4

  • Adults 19 years of age or older
  • Patients requiring endoscopic retrograde cholangiography and drainage for therapeutic purposes.
  • Patients with imaging (CT, Cholangiogram) confirmed confluence of the cystic duct with the distal third of the common bile duct.
  • Patients who have voluntary informed consent to participate in the study.

Exclusion Criteria8

  • Patients who have undergone percutaneous/surgical bile duct or gallbladder drainage prior to study enrollment.
  • Patients with anatomic deformity of the upper gastrointestinal tract after gastric or hepatobiliary surgery
  • Patients with concomitant gastric/duodenal obstruction
  • Patients with confirmed or suspected cystic duct obstruction on imaging studies
  • Patients with acute cholecystitis, acute pancreatitis
  • Patients who underwent cholecystectomy
  • Patients with a life expectancy of less than 3 months
  • Patients who are otherwise unable to undergo endoscopic retrograde cholangiopancreatography

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndoscopic transpapillary gallbladder drainage (ETGBD)

Fully covered self-Expandable metal stent with Endoscopic transpapillary gallbladder drainage (ETGBD) in patient with cystic duct low insertion


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06287112


Related Trials